Eduardo Hallak, partner, will participate in the Pharma & Biotech Patent Litigation Europe, scheduled for January 21 and 22 in Amsterdam. Mr. Hallak will feature as a speaker on the panel “Will the UPC Get the Doctrine of Equivalents Right? Comparing National Case Law with UPC Case Law in the Life Science Sector”. The event will gather leading professionals in the field to discuss the latest developments and strategies in pharmaceutical and biotech patent litigation. Find out more at: https://pharmabiotechpatentlitigation.com/events/patent-litigation-summit